Drug Shortage Report for VAQTA

Last updated on 2023-02-22 History
Report ID 178347
Drug Identification Number 02229702
Brand name VAQTA
Common or Proper name hepatitis A vaccine, purified inactivated Suspension for injection
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS A VACCINE, INACTIVATED
Strength(s) 50UNIT
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 50U/1ML 1DOSE VIAL
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2022-12-14
Estimated end date 2023-03-10
Actual end date 2023-02-21
Shortage status Resolved
Updated date 2023-02-22
Company comments Remaining doses are reserved for the public immunization program.
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2023-02-22 English Compare
v5 2023-02-21 French Compare
v4 2023-02-21 English Compare
v3 2022-12-15 English Compare
v2 2022-12-14 French Compare
v1 2022-12-14 English Compare

Showing 1 to 6 of 6